Extendicare (TSE:EXE) Reaches New 12-Month High – What’s Next?

Extendicare Inc. (TSE:EXEGet Free Report)’s stock price reached a new 52-week high on Monday . The company traded as high as C$13.13 and last traded at C$13.08, with a volume of 67465 shares. The stock had previously closed at C$13.04.

Analysts Set New Price Targets

EXE has been the subject of a number of recent research reports. Cormark raised Extendicare to a “moderate buy” rating in a research report on Wednesday, February 19th. TD Securities upped their price objective on Extendicare from C$10.50 to C$13.00 and gave the stock a “hold” rating in a research note on Monday, March 3rd. BMO Capital Markets upped their price objective on Extendicare from C$11.00 to C$13.50 in a research note on Monday, March 3rd. Finally, Royal Bank of Canada upped their price objective on Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 28th.

View Our Latest Report on EXE

Extendicare Trading Up 0.1 %

The business has a 50 day moving average price of C$11.00 and a 200-day moving average price of C$9.98. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02. The company has a market cap of C$1.09 billion, a P/E ratio of 16.69 and a beta of 1.26.

Extendicare Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 17th will be paid a $0.04 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 3.67%. The ex-dividend date of this dividend is Friday, February 28th. Extendicare’s dividend payout ratio (DPR) is presently 61.20%.

Extendicare Company Profile

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Featured Articles

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.